Koyfin Home > Directory > Health Care > Iovance Biotherapeutics Inc > Cash from Financing Activities

Iovance Biotherapeutics Inc Cash from Financing Activities Chart (IOVA)

Iovance Biotherapeutics Inc annual/quarterly Cash from Financing Activities from 2010 to 2020.
  • Iovance Biotherapeutics Inc Cash from Financing Activities for the quarter ending June 06, 2020 was $568m a 99.88% increase of 568m year over year
  • Iovance Biotherapeutics Inc Cash from Financing Activities for the last 12 months ending June 06, 2020 was $575m a 57.68% increase of 332m year over year
  • Iovance Biotherapeutics Inc Annual Cash from Financing Activities for 2019 was $6m a -6,820.68% decrease of -418m from 2018
  • Iovance Biotherapeutics Inc Annual Cash from Financing Activities for 2018 was $424m a 86.17% increase of 366m from 2017
  • Iovance Biotherapeutics Inc Annual Cash from Financing Activities for 2017 was $59m a -65.12% decrease of -38m from 2016
Other Cash Flow Metrics:
  • Iovance Biotherapeutics Inc Cash Flow from Operations for the quarter ending September 09, 2018 was $-28m a 24.94% decrease of -7m year over year
  • Iovance Biotherapeutics Inc Levered Free Cash Flow (FCF) for the quarter ending September 09, 2018 was $-16m a 52.18% decrease of -9m year over year
View Chart On Koyfin

Quarterly IOVA Cash from Financing Activities Data

06/2020$568m
03/2020$4m
12/2019$2m
09/2019$1m
06/2019$3m
03/2019$0m
12/2018$239m
09/2018$12m
06/2018$3m
03/2018$170m

Annual IOVA Cash from Financing Activities Data

2019$6m
2018$424m
2017$59m
2016$97m
2015$78m
2014$35m
2013$23m
2012$2m
2011$5m
2010$2m